Growth | CHOP Research Institute
 

Growth

The Mitchell Lab uses epidemiological methods to investigate determinants of energetic behavior.

The purpose of this study is to look at growth using a novel technique called diffusion tensor imaging (DTI) of the  growth plate in the knee. 

The MAGIC Study is looking at the microbiome as it develops during the first two years of life. It brings together expertise in the microbiome, antibiotic stewardship, immunology, neonatology, and infectious diseases to study the effect that health and environment have on the microbiome and growth.

The Children’s Hospital of Philadelphia is seeking healthy adolescents between the ages of 12-13, who are currently in the 7th grade, to participate in the Sleep and Growth Study 2. 

The purpose of this study is to examine breathing in healthy children ages 6-18 so that we may better understand the changes in function due to growth and the increase in size of the body organs.

The McCormack Lab studies the intersection of neuroendocrinology and metabolism, with two areas of focus. First, the lab studies genetic disorders with increased risk for diabetes mellitus, including mitochondrial diseases. Second, investigators in the lab focus on brain tumor-related hypothalamic obesity syndrome.

Published on
Sep 19, 2017
Bone mineral accrual doesn't keep pace with height growth prior to adolescence, according to a national study. After a teenager reaches adult height, bone mineral accrual tends to play catch-up: Roughly 10 percent of bone mass continues to accumulate after height growth is complete. The study findings also suggest that bone growth is site-specific, with bone mineral density developing at different rates in different parts of the skeleton.
Published on
Jul 13, 2017
CAR T-cell therapy tops this week's research roundup, with news about the experimental immunotherapy designed to re-engineer a patient's cells to fight cancer making late-breaking and captivating headlines across the nation.
Published on
Jun 18, 2015
A study published in the Journal of Clinical Endicronology & Metabolism shows a drug approved to treat Crohn’s disease and ulcerative colitis leads to “rapid improvements” in bone density and structure.
Published on
Feb 22, 2013
Children who are born with complex heart defects like congenital heart disease can often have poor growth. A new study from a pediatric cardiologist and her team at The Children's Hospital of Philadelphia suggests that that this poor growth may stem from factors beyond deficient nutrition, and may include abnormalities in overall growth regulation.

Meryl S. Cohen, MD, of the Cardiac